JP2025509846A5 - - Google Patents

Info

Publication number
JP2025509846A5
JP2025509846A5 JP2024555367A JP2024555367A JP2025509846A5 JP 2025509846 A5 JP2025509846 A5 JP 2025509846A5 JP 2024555367 A JP2024555367 A JP 2024555367A JP 2024555367 A JP2024555367 A JP 2024555367A JP 2025509846 A5 JP2025509846 A5 JP 2025509846A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
compound
oxygen
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024555367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509846A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/015024 external-priority patent/WO2023177593A1/en
Publication of JP2025509846A publication Critical patent/JP2025509846A/ja
Publication of JP2025509846A5 publication Critical patent/JP2025509846A5/ja
Pending legal-status Critical Current

Links

JP2024555367A 2022-03-14 2023-03-10 フェニルトリアゾールmll1-wdr5タンパク質-タンパク質間相互作用阻害剤 Pending JP2025509846A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263319582P 2022-03-14 2022-03-14
US63/319,582 2022-03-14
PCT/US2023/015024 WO2023177593A1 (en) 2022-03-14 2023-03-10 Phenyl triazole mll1-wdr5 protein-protein interaction inhibitor

Publications (2)

Publication Number Publication Date
JP2025509846A JP2025509846A (ja) 2025-04-11
JP2025509846A5 true JP2025509846A5 (cg-RX-API-DMAC7.html) 2026-03-17

Family

ID=87932382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024555367A Pending JP2025509846A (ja) 2022-03-14 2023-03-10 フェニルトリアゾールmll1-wdr5タンパク質-タンパク質間相互作用阻害剤

Country Status (7)

Country Link
US (1) US20230286925A1 (cg-RX-API-DMAC7.html)
EP (1) EP4493182A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025509846A (cg-RX-API-DMAC7.html)
KR (1) KR20250023339A (cg-RX-API-DMAC7.html)
CA (1) CA3245868A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024011348A (cg-RX-API-DMAC7.html)
WO (1) WO2023177593A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109734674B (zh) * 2019-02-26 2022-08-26 中国药科大学 苯胺类wdr5蛋白-蛋白相互作用抑制剂及其制法和用途
WO2025155755A1 (en) * 2024-01-16 2025-07-24 Rutgers, The State University Of New Jersey Sterically hindered 1h-1,2,3-triazol-5-ylidene abnormal n-heterocyclic carbene (anhc) ligands, catalyst complexes thereof, and methods using same
TW202619730A (zh) 2024-09-13 2026-05-16 日商亞力維克希斯股份有限公司 Wdr5抑制劑、化合物、醫藥組合物、及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7511042B2 (en) * 2003-12-03 2009-03-31 Boehringer Ingelheim Pharmaceuticals, Inc. Triazole compounds
WO2015187827A1 (en) * 2014-06-03 2015-12-10 The Trustees Of The University Of Pennsylvania Novel effective antiviral compounds and methods using same
US11319299B2 (en) * 2016-03-01 2022-05-03 Propellon Therapeutics Inc. Substituted carboxamides as inhibitors of WDR5 protein-protein binding
JP2020532561A (ja) * 2017-09-06 2020-11-12 プロペロン セラピューティクス インコーポレイテッド Wdr5タンパク質−タンパク質結合の阻害剤
CN108715585A (zh) * 2018-04-23 2018-10-30 中国药科大学 苯基联三氮唑类mll1-wdr5蛋白-蛋白相互作用抑制剂
JP2021527666A (ja) * 2018-06-21 2021-10-14 アイカーン スクール オブ メディスン アット マウント シナイ Wd40反復ドメインタンパク質5(wdr5)分解/破壊化合物および使用の方法

Similar Documents

Publication Publication Date Title
US10301278B2 (en) 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP7611278B2 (ja) 金属酵素阻害剤化合物
JP6534675B2 (ja) mIDH1阻害剤としてのベンズイミダゾール−2−アミン
DK2526090T3 (en) New antimalarials
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
JP2014526500A5 (cg-RX-API-DMAC7.html)
WO2020247747A1 (en) Bicyclic derivatives for treating endoparasites
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2011504903A5 (cg-RX-API-DMAC7.html)
CA2710182A1 (en) Pyrimidyl indoline compound
JP2005517006A5 (cg-RX-API-DMAC7.html)
CA2628844A1 (en) Pyrazole derivatives and their medical use
CA2991360A1 (en) 2-aryl- and 2-arylalkyl-benzimidazoles as midh1 inhibitors
JP2015524843A5 (cg-RX-API-DMAC7.html)
JP2023512823A5 (cg-RX-API-DMAC7.html)
JP2022542140A5 (cg-RX-API-DMAC7.html)
JP2021529174A5 (cg-RX-API-DMAC7.html)
RU2403253C2 (ru) Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а
US20240279207A1 (en) Substituted acyl sulfonamides for treating cancer
JP2004525183A5 (cg-RX-API-DMAC7.html)
RU2011108485A (ru) Новые (поли)аминоалкиламиноалкиламидные, алкилмочевинные или алкилсульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств
JP6184866B2 (ja) 新規抗がん剤
ES2715394T3 (es) Nuevo antifúngico derivado de oxodihidropiridinacarbohidrazida
JP2026505827A (ja) 治療剤として使用することができる新規化合物